Skip to main content
. 2021 Mar 8;4:310. doi: 10.1038/s42003-021-01790-2

Fig. 1. Schematic overview of designed Albu-LiTE constructs.

Fig. 1

The bispecific LiTE molecule (49 kDa) containing an anti-EGFR nanobody (green) linked to anti-CD3 scFv (blue). HSA (red) and point mutationed variants (yellow dots) with different affinities for human FcRn were genetically fused with the LiTE and expressed as a single polypeptide (108 kDa).